| EMED Mining Public Limited: Director's Share Purchase | |
| | |
|
NICOSIA, CYPRUS--(Marketwired - Aug 21, 2014) - EMED Mining Public Limited (AIM: EMED) (TSX: EMD)
LSE: EMED; TSX: EMD
AIM: EMED
Director's Share Purchase
EMED Mining Public Limited ("EMED Mining" or the "Company") has been notified that on 19 August 2014, Alberto Lavandeira, Chief Operating Officer of the Company, purchased 1 million ordinary shares in EMED Mining at an average price of C$0.135.
Following this purchase, Mr Lavandeira holds the following interests in EMED Mining:
|
Number
of
Ordinary
Shares
Beneficially
Owned |
|
% of
Company's
Issued
Share
Capital |
|
Restricted
shares
held in
escrow (1) |
|
Share
Options (2) |
A Lavandeira |
1,000,000 |
|
0.07 |
|
2,000,000 |
|
6,000,0000 |
(1) These shares were issued at a price of 0.25 pence per share following approval at the AGM on 11 June 2014 and are held in escrow and only released once Mr Lavandeira has been employed by the Company for two years or his service agreement is terminated for certain reasons.
(2) The options were granted in March 2014 and are exercisable at 12 pence per share and have an expiry date of 5 years from the date of grant. The options vest in three equal tranches on the first, second and third anniversaries of the date of grant. Enquiries
EMED Mining |
Isaac Querub/Alberto Lavandeira |
+34 959 59 28 50 |
RFC Ambrian |
Samantha Harrison |
+44 203 440 6800 |
Fox-Davies Capital |
Oliver Stansfield |
+44 203 463 5061 |
Walbrook PR |
Nick Rome |
+44 207 933 8783 |
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
CODE : EMED.L |
ISIN : CY0000100319 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |